Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes
description
Transcript of Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes
Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes
Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes
Goals
Clinical Efficacy: GLP-1 Receptor Agonists
Addressing Patient-Related Barriers to GLP-1 Agonist Use
Promoting Adherence to GLP-1 Receptor Agonist Therapy
The Importance of Patient Education
Partnering With the Patient
Currently FDA-Approved GLP-1 Receptor Agonists
Adherent Patients More Likely to Achieve Glycemic Control
ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy
Pancreatic Safety of Incretin-based Drugs
Talking to Your Patient: Pancreatitis
Optimizing GLP-1 Receptor Agonists: Addressing Injection Phobia
Fixed Ratio Combinations: Clinical Efficacy
Key Takeaways
Abbreviations
References
References (cont)
References (cont)
References (cont)